Navigation Links
Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
Date:3/19/2008

yde dehydrogenase ("ALDH2") deficiency and nephropathic cystinosis.

For additional information, please visit http://www.raptorpharma.com.

About Patheon Pharmaceuticals Inc.

Patheon (TSX: PTI) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. The Company operates a network of 12 facilities in the United States, Canada and Europe, employing more than 4,650 people and serving a global client base of 250 pharmaceutical and biotechnology companies. For further information about Patheon, please visit http://www.patheon.com or contact the company at info@patheon.com or (905) 821-4001.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: the Company's ability to initiate a Phase 2a study of Cysteamine or Delayed Release Cysteamine in NASH patients in 2008, develop an oral formulation of 4MP, develop clinical assays for the oral formulation of 4MP and initiate a clinical trial for the oral formulation of 4MP in the second half of 2008. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Raptor Pharmaceuticals Acquires Orphan Clinical Program
2. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
3. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
4. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
11. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... China , May 6, 2015 /PRNewswire/ ... ) – Beike Biotechnology, the world,s largest ... cord derived mesenchymal stem cell packets containing no ... This new product could significantly reduce the time ... especially in the case of degenerative conditions ...
(Date:5/6/2015)... 2015 Follow us on ... nanomaterial with diameter ranging between 2 to 10 ... nanophotonics materials market. The unique electroluminescent, photoluminescent, photo-physical, ... quantum confinement effect render the nanoparticles versatile and ... scientific, technological, and commercial applications. A host of ...
(Date:5/6/2015)... BALTIMORE , May 6, 2015   University ... LLC announced today the signing of an exclusive ... of Maryland, Baltimore (UMB) to develop diagnostics to detect ... and Crohn,s disease (CD). Drs. Florian Fricke ... while both were with the University of Maryland School ...
(Date:5/6/2015)... Fla. , May 6, 2015  Oxis Biotech, ... Inc. OTC: OXIS, OXI.PA, announced today that Cassian ... Division of Cancer Medicine at the University of Texas ... Dr. Yee is also Professor, Department of Immunology, Division ... Center for Cancer Immunology Research at the University of ...
Breaking Biology Technology:Beike Biotechnology Produces High-dose Adult Stem Cell Packets for Degenerative Conditions 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3
... SUNNYVALE, Calif., Sept. 14 Pharmacyclics, Inc. (Nasdaq: ... innovative small molecule drugs for the treatment of immune mediated ... results for the fourth quarter and fiscal year ended June ... 17, 2009 at 1:30 p.m. PDT (4:30 p.m. EDT). To ...
... , , JOHNSON CITY, Tenn., ... a potent radioprotectant as well as radiomitigator, protects against lethal, whole-body ... exposure. , , In recent experiments, the ... dose at either 48 or 72 hours after lethal, whole-body gamma ...
... , ... To achieve high levels of protein expression, many researchers have abandoned cloning in ... at a reasonable cost. Unlike a natural gene, a synthetic gene can be ... potential to be a huge advantage, as most researchers have come to accept ...
Cached Biology Technology:Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call 2Rx100 Rescues Life if Administered Up to 72 Hours After Exposure to Lethal, Whole-Body Radiation! 2DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 2DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 3DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 4
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... Nine faculty members from The University of Texas at ... The University of Texas System Board of Regents for ... with a $25,000 cash award and recognize faculty members ... performance and innovation at the undergraduate level. The professors ...
... Schools of Medicine and Dentistry has received an award of ... Refinement and Reduction of Animals in Research (NC3Rs), for a ... of mouse cell which could be used in place of ... lung conditions. Macrophages are crucial components of the immune ...
... UCLA that conducts kidney tests and transmits data through ... frequent office visits by people with diabetes and others ... device was developed in the research lab of Aydogan ... the UCLA Henry Samueli School of Engineering and Applied ...
Cached Biology News:9 UT Arlington educators honored for teaching excellence 2Funding for animal testing alternative 2UCLA researchers invent portable device for common kidney tests 2
... Novel Object Records behavior directed toward examining ... line is a family of instruments all built ... extraction software and that can track two fields ... Software automatically extracts animal positions and records ...
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... technology, SilenceMag is the most efficient ... and easy to use, SilenceMag is ... designed for siRNA delivery, SilenceMag allows ... doses of siRNA.,SilenceMag formulation gives reliable ...
... O 2 S 2 Formula ... crystalline powder Assay: greater than or ... Melting Point: greater than or equal ... or equal to 1% Storage: ...
Biology Products: